Latest Breaking News On - Investor contactlaurence wattsgilmartin group - Page 1 : comparemela.com

PepGen Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments

PepGen Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames mcarthurPepgen incInvestor contactlaurence wattsgilmartin groupAmerican academy of neurologyMedia contactgwendolyn schankerlifesci communicationsWorld muscle societyMuscular dystrophy association clinical scientific conferenceWall streetEnhanced delivery oligonucleotideAnnual congressWorld muscleDystrophy association clinicalScientific conferenceAmerican academyPrivate securities litigation reform act

PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress

PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPepgen duchenneJames mcarthurInvestor contactlaurence wattsgilmartin groupInternational hybrid annual congressMedia contactgwendolyn schankerlifesci communicationsPepgen incHead of clinical developmentWorld muscle society annual conferenceWorld muscle societyWall streetNova scotiaSenior vice presidentClinical developmentMichelle mellionEnhanced delivery oligonucleotide

PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy

PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames mcarthurInvestor contactlaurence wattsgilmartin groupMedia contactgwendolyn schankerlifesci communicationsPepgen incSafety review committeeEnhanced delivery oligonucleotideTissue concentrationExon skipping resultsMyotonic dystrophy typePrivate securities litigation reform act